Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
UnitedHealth Group Incorporated Canadian Depositary Receipt (UNH1)
Market Closed
17 Jul, 20:00
XFRA
All
(2)
DE
(1)
CA
(1)
XFRA
Primary
NEO-L
7.
30
-0.6
-7.5949%
5.9B
Market Cap
23.04
P/E Ratio
0.16%
Div Yield
80
Volume
22.88
Eps
7.9
Previous Close
Watching
Watch
Add Transaction
Day Range
7.25
7.3
Year Range
4.5
7.9
Want to track
UNH1
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
UnitedHealth Group Incorporated Canadian Depositary Receipt (UNH1) Statistics
Valuation metrics
Market Cap
5.9B
Enterprise value
51.6B
Trailing P/E (ttm)
0.57
Forward P/E
-
PEG ratio
8.79
Price/Sales (ttm)
0.01
Price/Book (mrq)
5.02
Enterprise Value/Revenue
0.13
Enterprise Value/EBITDA
2.8
Overview
Shares outstanding
907.68M
Float
905.44M
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
200
Average volume (90 days)
667
Price summary
52-Week low
4.5
52-Week high
7.9
Beta
0.65
50-Day moving average
5.8
200-Day moving average
5.52
Dividends and splits
Forward annual dividend rate
0.16
Forward annual dividend yield
0.0248%
Trailing annual dividend rate
0.08
Trailing annual dividend yield
0.0124%
5-Year annual dividend yield
-
Payout ratio
0.01
Dividend Date
16 Mar 2026
Ex-Dividend Date
9 Mar 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.03%
Operating margin
0.08%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.12%
Income Statement
Revenue (ttm)
386.56B
Revenue per share (ttm)
6.94
Quarterly revenue growth (yoy)
0.02%
Gross profit (ttm)
72.68B
EBITDA
23.16B
Net income to common (ttm)
10.35B
Diluted EPS (ttm)
11.4
Quarterly earnings growth (yoy)
-0%
Balance Sheet
Total cash (mrq)
26.84B
Total cash per share (mrq)
34.39
Total debt (mrq)
66.97B
Total Debt/Equity (mrq)
73.98
Current ratio (mrq)
0.8%
Book value per share (mrq)
1.29
Cash Flow
Cash flow statement
19.9B
Levered free cash flow (LFCF)
15.2B